Point72 Hong Kong Ltd Buys Shares of 3,515 Aspen Aerogels, Inc. (NYSE:ASPN)

Point72 Hong Kong Ltd purchased a new stake in shares of Aspen Aerogels, Inc. (NYSE:ASPNFree Report) in the second quarter, according to its most recent filing with the SEC. The firm purchased 3,515 shares of the construction company’s stock, valued at approximately $84,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of ASPN. Banque Cantonale Vaudoise raised its holdings in Aspen Aerogels by 37.5% during the first quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock worth $81,000 after purchasing an additional 1,252 shares during the last quarter. nVerses Capital LLC acquired a new position in shares of Aspen Aerogels during the 2nd quarter worth $95,000. Point72 DIFC Ltd purchased a new stake in shares of Aspen Aerogels in the 2nd quarter worth about $121,000. Public Employees Retirement Association of Colorado acquired a new stake in Aspen Aerogels in the 2nd quarter valued at about $145,000. Finally, NorthCrest Asset Manangement LLC purchased a new position in Aspen Aerogels during the 2nd quarter valued at about $217,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

ASPN has been the topic of several recent research reports. TD Cowen increased their price target on shares of Aspen Aerogels from $36.00 to $41.00 and gave the company a “buy” rating in a research report on Tuesday, August 20th. HC Wainwright raised their price target on Aspen Aerogels from $25.00 to $30.00 and gave the stock a “buy” rating in a research report on Friday, August 9th. Benchmark reissued a “buy” rating and issued a $14.00 price target on shares of Aspen Aerogels in a report on Thursday, August 8th. Craig Hallum increased their price objective on Aspen Aerogels from $33.00 to $38.00 and gave the company a “buy” rating in a research note on Friday, June 14th. Finally, Roth Mkm reissued a “buy” rating and issued a $36.00 target price on shares of Aspen Aerogels in a research note on Wednesday, August 21st. One analyst has rated the stock with a sell rating, nine have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $29.70.

Read Our Latest Research Report on Aspen Aerogels

Aspen Aerogels Stock Up 4.9 %

ASPN opened at $28.54 on Friday. Aspen Aerogels, Inc. has a 12 month low of $6.62 and a 12 month high of $33.15. The business has a 50-day moving average of $25.02 and a two-hundred day moving average of $23.48. The company has a debt-to-equity ratio of 0.23, a current ratio of 3.46 and a quick ratio of 2.82. The stock has a market capitalization of $2.17 billion, a price-to-earnings ratio of -64.85 and a beta of 2.16.

Aspen Aerogels (NYSE:ASPNGet Free Report) last released its earnings results on Wednesday, August 7th. The construction company reported $0.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.05 by $0.16. The firm had revenue of $117.80 million during the quarter, compared to the consensus estimate of $101.99 million. Aspen Aerogels had a net margin of 0.39% and a return on equity of 0.74%. Aspen Aerogels’s revenue was up 144.4% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.22) earnings per share. On average, research analysts expect that Aspen Aerogels, Inc. will post 0.21 earnings per share for the current year.

Insider Transactions at Aspen Aerogels

In related news, CFO Ricardo C. Rodriguez sold 32,465 shares of Aspen Aerogels stock in a transaction on Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the transaction, the chief financial officer now owns 20,790 shares in the company, valued at $626,610.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 4.30% of the company’s stock.

Aspen Aerogels Company Profile

(Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Read More

Want to see what other hedge funds are holding ASPN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aspen Aerogels, Inc. (NYSE:ASPNFree Report).

Institutional Ownership by Quarter for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.